Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2001

View Archived Issues

Licensing opportunity from NIH: peptides that stabilize protein antigens

Licensing opportunity from NIH: neutralization site of HEV and use in vaccination

Licensing opportunity from NIH: N-CAM isoforms and psychiatric diseases

Baxter achieves significant R&D milestones during 2000

Oxagen and Incyte partner for gene-based osteoporosis research

Icos reports product pipeline update

Newly designed, highly active SOD mimetic protects against SAO shock

Peripherally administered Ono-8711 reduces postoperative mechanical hyperalgesia in rats

IY-81149 emerges from general pharmacological testing as potentially safe antiulcer drug

Kosan receives NCI grant to improve epothilone production

Caelyx receives approval in Canada for treatment of advanced ovarian cancer

Middle-aged women may reduce stroke risk by consuming more fish

Novel antibacterial substances designed to specifically inhibit bacterial enzymes

Antiinflammatory compounds in development at Abbott inhibit adhesion molecules

Lilly claims new modulators of metabotropic glutamate receptors and their uses

Recent patent covers Lilly's new muscarinic agents

New derivatives of echinocandin and their antifungal activity discussed in recent patents

Nortran's RSD-1235 shows efficacy in canine atrial arrhythmia model

Bradykinin fragment may offer a novel therapeutic strategy for septic shock

Phase II/III trial with OP-2000 for ulcerative colitis initiated

Potential Rx for neuropathic pain enters U.S. phase II trials

Organon licenses Cortex's Ampakines for depression

NIH funds will advance research on HIV vaccines at VaxGen

Nastech begins phase I trial of intranasal interferon alfa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...